Generali Investments Cee, Investicni Spolecnost, A.S. Amgen Inc Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $1.07 Trillion
- Q1 2025
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Amgen Inc stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 14,170 shares of AMGN stock, worth $3.93 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
14,170
Previous 14,720
3.74%
Holding current value
$3.93 Million
Previous $3.84 Billion
15.07%
% of portfolio
0.41%
Previous 0.4%
Shares
2 transactions
Others Institutions Holding AMGN
# of Institutions
3,311Shares Held
429MCall Options Held
8.06MPut Options Held
7.7M-
Vanguard Group Inc Valley Forge, PA52.9MShares$14.7 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.1 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.63 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.5 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $148B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...